Last reviewed · How we verify
Urothelial carcinoma
Approved treatments
- PF-07220060 + PF-07104091 combination dose escalation · Pfizer
- Pf-06882961 · Pfizer
Not specified
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urothelial carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Urothelial carcinoma treatment landscape brief
- Urothelial carcinoma treatment updates RSS
Frequently asked questions about Urothelial carcinoma
What drugs treat Urothelial carcinoma?
Tracked treatments include PF-07220060 + PF-07104091 combination dose escalation, Pf-06882961.
What is the treatment for Urothelial carcinoma?
Standard treatment for Urothelial carcinoma includes PF-07220060 + PF-07104091 combination dose escalation, Pf-06882961. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urothelial carcinoma patent cliff · Urothelial carcinoma CI report
- Treatment: PF-07220060 + PF-07104091 combination dose escalation · Pfizer
- Treatment: Pf-06882961 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing